Back to top
more

DexCom (DXCM)

(Real Time Quote from BATS)

$136.58 USD

136.58
2,043,814

+2.02 (1.50%)

Updated Apr 16, 2024 03:53 PM ET

After-Market: $136.72 +0.14 (0.10%) 4:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for DXCM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for DexCom, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 2,724 2,456 2,731 2,708 1,533
Receivables 974 713 514 429 286
Notes Receivable 0 0 0 0 0
Inventories 560 307 357 235 120
Other Current Assets 168 193 82 54 30
Total Current Assets 4,426 3,669 3,684 3,425 1,969
Net Property & Equipment 1,113 1,056 802 515 321
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 419 341 221 216 0
Intangibles 160 199 69 19 19
Deposits & Other Assets 75 47 0 21 14
Total Assets 6,265 5,392 4,864 4,291 2,395
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 773 0 0 0
Accounts Payable 1,346 902 573 481 256
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 171 134 125 114 89
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 18 10 2 2 2
Total Current Liabilities 1,556 1,839 721 614 360
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 2,434 1,198 1,703 1,667 1,060
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 126 128 90 81 20
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 4,196 3,260 2,612 2,464 1,512
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 3,515 2,258 2,505 2,125 1,676
Retained Earnings 1,021 480 -47 -202 -696
Other Equity -17 -12 1 3 2
Treasury Stock 2,451 595 206 100 100
Total Shareholder's Equity 2,069 2,132 2,252 1,827 883
Total Liabilities & Shareholder's Equity 6,265 5,392 4,864 4,291 2,395
Total Common Equity 2,069 2,132 2,252 1,827 883
Shares Outstanding 386.30 386.20 387.60 384.10 366.10
Book Value Per Share 5.35 5.52 5.81 4.76 2.41

Fiscal Year End for DexCom, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 2,724 3,240 3,636 2,567
Receivables NA 974 786 751 637
Notes Receivable NA 0 0 0 0
Inventories NA 560 499 421 366
Other Current Assets NA 168 174 195 198
Total Current Assets NA 4,426 4,698 5,003 3,767
Net Property & Equipment NA 1,113 1,079 1,078 1,076
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 419 501 417 349
Intangibles NA 160 170 180 189
Deposits & Other Assets NA 75 74 67 57
Total Assets NA 6,265 6,596 6,821 5,516
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 124 774 773
Accounts Payable NA 1,346 1,373 1,157 965
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 171 151 109 95
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 18 9 9 10
Total Current Liabilities NA 1,556 1,679 2,070 1,865
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 2,434 2,432 2,431 1,199
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 134 133 130
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 4,196 4,328 4,720 3,283
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 3,515 3,618 2,269 2,306
Retained Earnings NA 1,021 765 644 529
Other Equity NA -17 -36 -29 -7
Treasury Stock NA 2,451 2,080 784 595
Total Shareholder's Equity NA 2,069 2,268 2,100 2,233
Total Liabilities & Shareholder's Equity NA 6,265 6,596 6,821 5,516
Total Common Equity 0 2,069 2,268 2,100 2,233
Shares Outstanding 385.50 386.30 386.30 387.80 387.60
Book Value Per Share 0.00 5.35 5.87 5.42 5.76